Navigation Links
Genaera Corporation Announces Second Quarter Financial Results
Date:8/11/2008

periods in 2007. The decrease in the three-month period ended June 30, 2008 was due principally to decreases in realignment costs, bonus expense, public company expenses and accounting fees. The decrease was partially offset by an increase in stock-based compensation expense. The increase in the six-month period ended June 30, 2008 was due principally to an increase in stock-based compensation expense. This increase was partially offset by decreases in realignment costs, payroll expenses, bonus expense, accounting fees and public company expenses.

The Company's cash, cash equivalents and short-term investment balance was $12.8 million at June 30, 2008.

About Genaera

Genaera Corporation is focused on advancing the science and treatment of metabolic diseases. The Company has significant market opportunities with a first-in-class molecule, trodusquemine (MSI-1436), that has the potential to redefine the treatment paradigm for obesity and type 2 diabetes and is presently in a phase 1 trial in obesity. In addition, Genaera has a value-driven, fully out-licensed partnership with MedImmune, Inc. for a second core program that is presently undergoing phase 2 clinical testing in asthma. Genaera is committed to directing resources to its core program and the aggressive clinical development of its key assets to build stockholder value. For further information, please see our website at http://www.genaera.com.

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties, known and unknown. Forward-looking statements reflect management's current views and are based on certain expectations and assumptions. Such statements include, among others, statements regarding the preliminary results, clinical development plans and prospects for Genaera's programs including trodusquemine (MSI-1436) and t
'/>"/>

SOURCE Genaera Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Genaera Elects New Board Member and Announces Executive Appointments
2. Genaera to Present at Biotech 2007 and BIO InvestorForum
3. Genaera Corporation Announces Third Quarter Financial Results
4. Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference
5. Genaera Corporation Announces 2007 Financial Results
6. Genaera Corporation Announces First Quarter Financial Results
7. Genaera Corporation to Present at BIO Business Forum
8. Genaera Corporation Elects Paul K. Wotton to Board of Directors
9. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
10. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
11. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)...  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology ... today announced that all outstanding common share purchase warrants ... their expiry on June 15, 2015, resulting in total ... "We thank our shareholders for their continued support," said ... "This exercise of warrants represents a strong vote of ...
(Date:5/26/2015)... NEW YORK , May 26, 2015 US-Australian drug ... announced today that it will present at the 2015 Marcum ... New York City at the Grand Hyatt Hotel. ... Novogen Chairman and CEO, is scheduled to begin at 9.30 a.m. ... the webcast, go to http://wsw.com/webcast/marcum3/nvgn . The ...
(Date:5/25/2015)... (PRWEB) May 26, 2015 Where is ... Jack Uldrich says, "The honest answer is that nobody ... four keynote speeches throughout the month of June, starting ... topics vary from future-proofing to top tech trends. And ... research is where the universe is expanding to. According ...
(Date:5/22/2015)... 22, 2015 According to a ... & 2D Gel Electrophoresis, Agarose & Polyacrylamide Gel, Capillary ... by Application & by End User - Global Forecast ... expected to reach around $1.98 Billion by 2020 with ... to 2020. Browse 226 ma ...
Breaking Biology Technology:Asterias Biotherapeutics Receives $11.7 Million in Proceeds from Exercise of Warrants 2Asterias Biotherapeutics Receives $11.7 Million in Proceeds from Exercise of Warrants 3Novogen to Present at the 2015 Marcum Microcap Conference 2Novogen to Present at the 2015 Marcum Microcap Conference 3Novogen to Present at the 2015 Marcum Microcap Conference 4Futurist Jack Uldrich Says Embracing Our Ignorance is the Key to Unlearning 2Futurist Jack Uldrich Says Embracing Our Ignorance is the Key to Unlearning 3Electrophoresis Market Worth $1.98 Billion by 2020 2Electrophoresis Market Worth $1.98 Billion by 2020 3Electrophoresis Market Worth $1.98 Billion by 2020 4
... CSL Behring announced today that treatment ... hours of the onset of an acute hereditary angioedema ... according to data presented at the 2012 American Academy of ... treated within six hours of attack onset and those treated ...
... grown from silver could be the basis of a new ... California, Davis. "We expect these structures will allow us ... Osterloh, a principal investigator on the $100,000 grant. Fractals ... case, branches of silver 1-50th the width of a human ...
... Inc., (OTCQB: ONVO) the San Diego-based regenerative medicine ... human tissue printing technology to create tissue on ... that their March 1st RetailInvestorConferences.com presentation is now ... www.retailinvestorconferences.com > red "register/ watch event ...
Cached Biology Technology:CSL Behring Study Confirms Early Treatment with Berinert® Provides Faster Resolution of Acute Hereditary Angioedema Symptoms 2CSL Behring Study Confirms Early Treatment with Berinert® Provides Faster Resolution of Acute Hereditary Angioedema Symptoms 3CSL Behring Study Confirms Early Treatment with Berinert® Provides Faster Resolution of Acute Hereditary Angioedema Symptoms 4Organovo, Inc. Investor Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com 2
(Date:5/18/2015)... Fingerprint Cards (FPC) has received an order for ... from one if its module partners. Deliveries are planned to ... the sensors will be used by smartphone manufacturers in ... amount to 740 MSEK to date. In addition to previously ... number of smaller orders not separately communicated amounting to more ...
(Date:5/14/2015)... , May 14, 2015  Verificient ... identity verification and online remote proctoring, announced ... software-as-a-service (SaaS) company and creator of the ... of the two companies will benefit from ... Canvas. As a fully integrated ...
(Date:5/11/2015)... a well-rounded UAS delegation representing private industry, government, and academia, ... AUVSI,s Unmanned 2015 conference last week in Atlanta ... UAS industry met with over 200 hundred people from companies ... ecosystem. "Our message is clear and consistent," ... Rich Knoll . "If you want to fly UAS, you ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2
... now have access to a free application that ... natural gas, biodiesel, e85 Ethanol, propane and hydrogen. ... (NREL) developed the new mobile application for DOE,s ... across the country in an effort to cut ...
... German . The normal ... Arabidopsis thaliana uses the same genetic changes in ... half as found in semi-dwarf varieties of rice and barley that have ... apparently fall back on the same genes in their genotype. There must ...
... to fight the pain associated with abdominal surgery may ... the amount of time it takes to recover from ... of Colorado Boulder. The research team from CU-Boulder,s ... postdoctoral research fellow, together with Erika Galer, a professional ...
Cached Biology News:NREL developed mobile app for alternative fueling station locations released 2The secret of short stems 2The secret of short stems 3Using morphine after abdominal surgery may prolong pain, CU-Boulder researchers find 2
... The tubing prep station, 100-120 V, is ... with DNA-coated gold particles to create the source ... helium discharge with the Helios gene gun. The ... O-rings, tubing prep unit, 12 foot Nalgene nitrogen ...
... The Helios gene gun low-pressure system, 220-240 V, ... into cells. This handheld device employs an adjustable ... biomaterial-coated gold microcarriers from the inner wall of ... This system can be used for in situ, ...
... gene gun system, 220-240 V, is used ... cells. This handheld device employs an adjustable ... other biomaterial-coated gold microcarriers from the inner ... into target cells. This system has a ...
The Discovery Series PDQuest 2-D analysis software is used for imaging, analyzing, and databasing two-dimensional electrophoretic gels. The 10-user network license entitles ten users to access data f...
Biology Products: